Mental health problems: Are they or are they not a risk factor for dropout from drug treatment? A systematic review of the evidence

References

• Agosti V, Nunes E, et al. Patient factors related to early attrition from an outpatient cocaine research clinic. American Journal of Drug and Alcohol Abuse 1996; 22(1)29–39
   PubMed Web of Science ®Google Scholar
• Alterman AI, Rutherford MJ, et al. Response to methadone maintenance and counseling in antisocial patients with and without major depression. Journal of Nervous and Mental Disease 1996; 184(11)695–702
   PubMed Web of Science ®Google Scholar
• Araujo L, Goldberg P, et al. The effect of anxiety and depression on completion/withdrawal status in-patients admitted to substance abuse detoxification program. Journal of Substance Abuse Treatment 1996; 13(1)61–66
   PubMed Web of Science ®Google Scholar
• Avants SK, Margolin A, et al. Day treatment versus enhanced standard methadone services for opioid-dependent patients: A comparison of clinical efficacy and cost. American Journal of Psychiatry 1999; 156(1)27–33
   PubMed Web of Science ®Google Scholar
• Avants SK, Warburton LA, et al. The influence of coping and depression on abstinence from illicit drug use in methadone-maintained patients. American Journal of Drug and Alcohol Abuse 2000; 26(3)399–416
   PubMed Web of Science ®Google Scholar
• Ball SA, Cobb-Richardson P, et al. Substance abuse and personality disorders in homeless drop-in center clients: Symptom severity and psychotherapy retention in a randomized clinical trial. Comprehensive Psychiatry 2005; 46(5)371–379
   PubMed Web of Science ®Google Scholar
• Brady TM, Krebs CP, et al. Psychiatric comorbidity and not completing jail-based substance abuse treatment. American Journal of Addiction 2004; 13(1)83–101
   PubMed Web of Science ®Google Scholar
• Broome KM, Flynn PM, et al. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research 1999; 34(3)791–806
   PubMed Web of Science ®Google Scholar
• Bryant KJ, Rounsaville B, et al. Reliability of dual diagnosis. Substance dependence and psychiatric disorders. Journal of Nervous and Mental Disease 1992; 180(4)251–257
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Alterman AI, et al. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence 2001; 61(3)271–280
   PubMed Web of Science ®Google Scholar
• Carroll KM, Ball SA, et al. A comparison of alternate systems for diagnosing antisocial personality disorder in cocaine abusers. Journal of Nervous and Mental Disease 1993; 181(7)436–443
   PubMed Web of Science ®Google Scholar
• Charney DA, Paraherakis AM, et al. The impact of depression on the outcome of addictions treatment. Journal of Substance Abuse Treatment 1998; 15(2)123–130
   PubMed Web of Science ®Google Scholar
• Claus RE, Kindleberger LR. Engaging substance abusers after centralized assessment: Predictors of treatment entry and dropout. Journal of Psychoactive Drugs 2002; 34(1)25–31
   PubMed Web of Science ®Google Scholar
• Crawford V. Co-existing problems of mental health and substance misuse (‘dual diagnosis’). University College Research Unit, London 2001
   Google Scholar
• Curran GM, Kirchner JE, et al. Depressive symptomatology and early attrition from intensive outpatient substance use treatment. Journal of Behavioral Health Services & Research 2002; 29(2)138–143
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, et al. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence. Addiction 2005; 100(8)1121–1130
   PubMed Web of Science ®Google Scholar
• Epstein EE, McCrady BS, et al. Attrition from conjoint alcoholism treatment: Do dropouts differ from completers?. Journal of Substance & Abuse 1994; 6(3)249–265
   PubMedGoogle Scholar
• Franken IH, Hendriks VM. Screening and diagnosis of anxiety and mood disorders in substance abuse patients. American Journal of Addiction 2001; 10(1)30–39
   PubMed Web of Science ®Google Scholar
• Galanter M, Egelko S, et al. Can cocaine addicts with severe mental illness be treated along with singly diagnosed addicts?. American Journal of Drug & Alcohol Abuse 1996; 22(4)497–507
   PubMed Web of Science ®Google Scholar
• Gerra G, Leonardi C, et al. Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Progress in Neuropsychopharmacology and Biological Psychiatry 2006; 30(2)265–272
   PubMed Web of Science ®Google Scholar
• Gerstley LJ, Alterman AI, et al. Antisocial personality disorder in-patients with substance abuse disorders: A problematic diagnosis?. American Journal of Psychiatry 1990; 147(2)173–178
   PubMed Web of Science ®Google Scholar
• Gill K, Nolimal D, et al. Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy. Drug and Alcohol Dependency 1992; 30: 247–252
   PubMed Web of Science ®Google Scholar
• Goldstein MF, Deren S, et al. An alternative program for methadone maintenance dropouts: Description and preliminary data. Mount Sinai Journal of Medicine 2001; 68(1)33–40
   PubMed Web of Science ®Google Scholar
• Gonzalez G, Feingold A, et al. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. American Journal of Drug and Alcohol Abuse 2003; 29(3)497–514
   PubMed Web of Science ®Google Scholar
• Gossop M, Marsden J, et al. NTORS at one year. Department of Health, London 1998
   Google Scholar
• Gossop M, Marsden J, et al. Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: Results from the National Treatment Outcome Research Study. British Journal of General Practice 1999a; 49(438)31–34
   PubMed Web of Science ®Google Scholar
• Gossop M, Marsden J, et al. Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence 1999b; 57(2)89–98
   PubMed Web of Science ®Google Scholar
• Green CA, Polen MR, et al. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. Journal of Substance Abuse Treatment 2002; 23(4)285–295
   PubMed Web of Science ®Google Scholar
• Greenberg W, Otero J, et al. Irregular discharges from a dual diagnosis unit. American Journal of Drug & Alcohol Abuse 1994; 20(3)355–371
   PubMed Web of Science ®Google Scholar
• Haller DL, Knisely JS, et al. Perinatal substance abusers: Factors influencing treatment retention. Journal of Substance Abuse Treatment 1997; 14(6)513–519
   PubMed Web of Science ®Google Scholar
• Haller DL, Miles DR. Psychopathology is associated with completion of residential treatment in drug dependent women. Journal of Addictive Diseases 2004; 23(1)17–28
   PubMed Web of Science ®Google Scholar
• Haller DL, Miles DR, et al. Psychopathology influences treatment retention among drug-dependent women. Journal of Substance Abuse Treatment 2002; 23(4)431–436
   PubMed Web of Science ®Google Scholar
• Hasin D, Samet S, et al. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. American Journal of Psychiatry 2006; 163(4)689–696
   PubMed Web of Science ®Google Scholar
• Hile MG, Adkins R E. The impact of substance abusers' readiness to change on psychological and behavioral functioning. Addicticve Behaviors 1998; 23: 365–370
   PubMed Web of Science ®Google Scholar
• Hiller ML, Knight K, et al. Prison-based substance abuse treatment, residential aftercare and recidivism. Addiction 1999; 94(6)833–842
   PubMed Web of Science ®Google Scholar
• Hser YI, Joshi V, et al. Effects of program and patient characteristics on retention of drug treatment patients. Evaluation & Program Planning 2001; 24(4)331–341
   Web of Science ®Google Scholar
• Hser YI, Evans E, et al. Relationship between drug treatment services, retention, and outcomes. Psychiatric Services 2004; 55(7)767–774
   PubMed Web of Science ®Google Scholar
• Joe GW, Simpson DD, et al. Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependency 1999; 57(2)113–125
   PubMed Web of Science ®Google Scholar
• King VL, Brooner RK, et al. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. Journal of Nervous and Mental Disease 1999; 187(8)487–495
   PubMed Web of Science ®Google Scholar
• King VL, Kidorf MS, et al. Influence of antisocial personality subtypes on drug abuse treatment response. Journal of Nervous and Mental Diseases 2001; 189(9)593–601
   PubMed Web of Science ®Google Scholar
• Identifying pregnant women at risk for early attrition from substance abuse treatment. Journal of Substance Abuse Treatment 2004; 27(1)31–38
   PubMed Web of Science ®Google Scholar
• Klein C, di Menza S, et al. Interaction effects of treatment setting and client characteristics on retention and completion. Journal of Psychoactive Drugs 2002; 34(1)39–50
   PubMed Web of Science ®Google Scholar
• Kleinman PH, Kang SY, et al. Retention of cocaine abusers in outpatient psychotherapy. American Journal of Drug and Alcohol Abuse 1992; 18(1)29–43
   PubMed Web of Science ®Google Scholar
• Knight DK, Logan SM, et al. Predictors of program completion for women in residential substance abuse treatment. American Journal of Drug and Alcohol Abuse 2001; 27(1)1–18
   PubMed Web of Science ®Google Scholar
• Kokkevi A, Stefanis N, et al. Personality disorders in drug abusers: Prevalence and their association with AXIS-I disorders as predictors of treatment retention. Addictive Behaviours 1998; 23(6)841–853
   PubMed Web of Science ®Google Scholar
• Lang MA, Belenko S. Predicting retention in a residential drug treatment alternative to prison program. Journal of Substance Abuse Treatment 2000; 19(2)145–160
   PubMed Web of Science ®Google Scholar
• Laudet AB. Attitudes and beliefs about 12-step groups among addiction treatment clients and clinicians: Toward identifying obstacles to participation. Substance Use & Misuse 2003; 38(14)2017–2047
   PubMed Web of Science ®Google Scholar
• Lewin TJ, Baker AL, et al. The ‘comorbidity roundabout’: A framework to guide assessment and intervention strategies and engineer change among people with comorbid problems. Drug and Alcohol Review 2004; 23: 307–423
   Google Scholar
• Lowe AL, Abou-Saleh MT. The British experience of dual diagnosis in the National Health Service. Acta Neuropsychiatrica 2004; 16: 41–46
   PubMed Web of Science ®Google Scholar
• Magura S., Nwakeze PC, Demsky SY. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998; 93: 51–60
   PubMed Web of Science ®Google Scholar
• Manning V, Strathdee G, et al. Dual diagnosis screening: Preliminary findings on the comparison of 50 clients attending community mental health services and 50 clients attending community substance misuse services. Journal of Substance Use 2002; 7(4)221–228
   Google Scholar
• Maremmani I, Zolesi O, et al. Methadone dose and retention during treatment of heroin addicts with Axis-I psychiatric comorbidity. Journal of Addictive Diseases 2000; 19(2)29–41
   PubMed Web of Science ®Google Scholar
• Marlowe DB, Kirby KC, et al. Impact of comorbid personality disorders and personality disorder symptoms on outcomes of behavioral treatment for cocaine dependence. Journal of Nervous and Mental Disease 1997; 185(8)483–490
   PubMed Web of Science ®Google Scholar
• Marsden J, Gossop M, et al. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. British Journal of Psychiatry 2000; 176: 285–289
   PubMed Web of Science ®Google Scholar
• Martinez-Raga J, Marshall EJ, et al. Unplanned versus planned discharges from in-patient alcohol detoxification: Retrospective analysis of 470 first-episode admissions. Alcohol Abuse 2002; 37(3)277–281
   Google Scholar
• McCaul ME, Svikis DS, et al. Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependency 2001; 62: 9–17
   PubMed Web of Science ®Google Scholar
• Meier PS, Best D. Programme factors that influence completion of residential treatment. Drug and Alcohol Review 2006; 25: 349–355
   PubMed Web of Science ®Google Scholar
• Meier PS, Donmall MC, et al. The role of the early therapeutic alliance in predicting drug treatment dropout. Drug and Alcohol Dependence 2006; 83(1)57–64
   PubMed Web of Science ®Google Scholar
• Mertens JR, Weisner CM. Predictors of substance abuse treatment retention among women and men in an HMO. Alcoholism: Clinical and Experimental Research 2000; 24(10)1525–1533
   PubMed Web of Science ®Google Scholar
• Mierlak D, Galanter M, et al. Modified therapeutic community treatment for homeless dually diagnosed men. Who completes treatment?. Journal of Substance Abuse Treatment 1998; 15(2)117–121
   PubMed Web of Science ®Google Scholar
• Moos RH, King MJ. Participation in community residential treatment and substance abuse patients’ outcomes at discharge. Journal of Substance Abuse Treatment 1997; 14(1)71–80
   PubMed Web of Science ®Google Scholar
• Nuttbrock LA, Rahav M, et al. Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community. Psychiatric Services 1998; 49(1)68–76
   PubMed Web of Science ®Google Scholar
• Pani PP, Trogu E., Contu P., Agus A., Gessa G. L. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug and Alcohol Dependence 1997; 48: 119–126
   PubMed Web of Science ®Google Scholar
• Petry NM, Bickel WK. Therapeutic alliance and psychiatric severity as predictors of completion of treatment for opioid dependence. Psychiatric Services 1999; 50(2)219–227
   PubMed Web of Science ®Google Scholar
• Ravndal E, Vaglum P. Psychopathology and substance abuse as predictors of program completion in a therapeutic community for drug abusers: A prospective study. Acta Psychiatrica Scandinavica 1991; 83: 217–222
   PubMed Web of Science ®Google Scholar
• Ross HE, Cutler M, et al. Retention in substance abuse treatment. Role of psychiatric symptom severity. American Journal of Addiction 1997; 6(4)293–303
   PubMed Web of Science ®Google Scholar
• Ryan RM, Plant RW, et al. Initial motivations for alcohol treatment: Relations with patient characteristics, treatment involvement, and dropout. Addictive Behaviours 1995; 20(3)279–297
   PubMed Web of Science ®Google Scholar
• Saxon AJ, Calsyn DA. Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic. American Journal of Drug and Alcohol Abuse 1995; 21(3)303–313
   PubMed Web of Science ®Google Scholar
• Saxon AJ, Wells EA, et al. Pretreatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 1996; 91(8)1197–1209
   PubMed Web of Science ®Google Scholar
• Sayre SL, Schmitz JM, et al. Determining predictors of attrition in an outpatient substance abuse program. American Journal of Drug and Alcohol Abuse 2002; 28(1)55–72
   PubMed Web of Science ®Google Scholar
• Schulte S. Treatment Options and Pathways for clients with Comorbidity (TOPCOM): A national survey. Manchester Metropolitan University, Manchester, UK 2007
   Google Scholar
• Simpson DD, Joe GW, et al. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence 1997; 47(3)227–235
   PubMed Web of Science ®Google Scholar
• Siqueland L, Crits-Christoph P, et al. Predictors of dropout from psychosocial treatment of cocaine dependence. Drug and Alcohol Dependence 1998; 52(1)1–13
   PubMed Web of Science ®Google Scholar
• Siqueland L, Crits-Christoph P, et al. Retention in psychosocial treatment of cocaine dependence: Predictors and impact on outcome. American Journal of Addiction 2002; 11(1)24–40
   PubMed Web of Science ®Google Scholar
• Stark MJ. Dropping out of substance abuse treatment: A clinically oriented review. Clinical Psychology Review 1992; 12: 93–116
   Web of Science ®Google Scholar
• Tidey JW, Mehl-Madrona L, et al. Psychiatric symptom severity in cocaine-dependent outpatients: Demographics, drug use characteristics and treatment outcome. Drug and Alcohol Dependence 1998; 50(1)9–17
   PubMed Web of Science ®Google Scholar
• Van Stelle K. R., Blumer C., Moberg DP. Treatment retention of dually diagnosed offenders in an institutional therapeutic community. Behavioral Sciences & the Law 2004; 22(4)585–97
   PubMed Web of Science ®Google Scholar
• Virgo N, Bennett G, et al. The prevalence and characteristics of co-occurring serious mental illness (SMI) and substance abuse or dependence in the patients of Adult Mental Health and Addictions Services in eastern Dorset. Journal of Mental Health 2001; 10(2)175–188
   Google Scholar
• Wallace AE, Weeks WB. Substance abuse intensive outpatient treatment: Does program graduation matter?. Journal of Substance Abuse Treatment 2004; 27(1)27–30
   PubMed Web of Science ®Google Scholar
• Weaver T, Madden P, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry 2003; 183: 304–313
   PubMed Web of Science ®Google Scholar
• Williamson PR, Gamble C. Identification and impact of outcome selection bias in meta-analysis. Statistics in Medicine 2005; 24: 1547–1561
   PubMed Web of Science ®Google Scholar
• Zhang Z, Friedmann PD, et al. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003; 98(5)673–684
   PubMed Web of Science ®Google Scholar